id	sid	eid	entity	type
ajlm-2613	1	1	a. jimoh department	PERSON
ajlm-2613	1	2	federal university of health sciences	ORG
ajlm-2613	1	3	nigeria	GPE
ajlm-2613	1	4	zainab a. adamu department	PERSON
ajlm-2613	1	5	ahmadu bello university	ORG
ajlm-2613	1	6	kaduna	GPE
ajlm-2613	1	7	nigeria	GPE
ajlm-2613	1	8	w. rasheed	PERSON
ajlm-2613	1	9	dutse	GPE
ajlm-2613	1	10	jigawa	GPE
ajlm-2613	1	11	nigeria	NORP
ajlm-2613	1	12	samuel k. richard department	PERSON
ajlm-2613	1	13	university of abuja	ORG
ajlm-2613	1	14	abuja	GPE
ajlm-2613	1	15	nigeria	GPE
ajlm-2613	1	16	jimoh aa	PERSON
ajlm-2613	1	17	adamu za	PERSON
ajlm-2613	1	18	rasheed mw	PERSON
ajlm-2613	1	19	richard sk	PERSON
ajlm-2613	1	20	african	NORP
ajlm-2613	1	21	northern nigeria	LOC
ajlm-2613	2	1	afr j	PERSON
ajlm-2613	3	1	2025;14(1	CARDINAL
ajlm-2613	3	2	a2613	CARDINAL
ajlm-2613	3	3	https://doi.org/10.4102/ajlm.v14i1.2613	CARDINAL
ajlm-2613	3	4	african	NORP
ajlm-2613	3	5	northern nigeria	LOC
ajlm-2613	3	6	a. jimoh	PERSON
ajlm-2613	3	7	zainab a. adamu	PERSON
ajlm-2613	3	8	mumini w. rasheed	PERSON
ajlm-2613	3	9	samuel k. richard	PERSON
ajlm-2613	3	10	24	CARDINAL
ajlm-2613	3	11	aug. 2024	DATE
ajlm-2613	3	12	07 apr. 2025	CARDINAL
ajlm-2613	3	13	30 july 2025	DATE
ajlm-2613	3	14	2025	CARDINAL
ajlm-2613	9	1	africa	LOC
ajlm-2613	10	1	northern nigeria	LOC
ajlm-2613	11	1	5-year	DATE
ajlm-2613	11	2	the cox-2 immunohistochemistry	ORG
ajlm-2613	11	3	aminu kano teaching hospital	ORG
ajlm-2613	11	4	kano	GPE
ajlm-2613	11	5	nigeria	GPE
ajlm-2613	11	6	between 01 january 2015 and	DATE
ajlm-2613	11	7	31 december 2019	DATE
ajlm-2613	13	1	29	CARDINAL
ajlm-2613	13	2	20	CARDINAL
ajlm-2613	13	3	9	CARDINAL
ajlm-2613	14	1	2.2:1	CARDINAL
ajlm-2613	14	2	40–79 years	DATE
ajlm-2613	14	3	62.1%	PERCENT
ajlm-2613	14	4	27.6%	PERCENT
ajlm-2613	14	5	10.3%	PERCENT
ajlm-2613	15	1	3.4%	PERCENT
ajlm-2613	17	1	only 3.4%	PERCENT
ajlm-2613	18	1	african	NORP
ajlm-2613	19	1	nigeria	GPE
ajlm-2613	19	2	africa	LOC
ajlm-2613	21	1	nigeria	GPE
ajlm-2613	21	2	28.8%	PERCENT
ajlm-2613	21	3	47.5%.1,2,3,4,5	CARDINAL
ajlm-2613	21	4	crc	ORG
ajlm-2613	22	1	2.9	CARDINAL
ajlm-2613	22	2	risk.10	GPE
ajlm-2613	22	3	1.8	CARDINAL
ajlm-2613	22	4	3.1	CARDINAL
ajlm-2613	22	5	crc development	ORG
ajlm-2613	22	6	adenomas.18	PRODUCT
ajlm-2613	22	7	africa	LOC
ajlm-2613	22	8	asia	LOC
ajlm-2613	23	1	african	NORP
ajlm-2613	24	1	northern nigeria	LOC
ajlm-2613	25	1	aminu kano teaching hospital	ORG
ajlm-2613	28	1	aminu kano teaching hospital	ORG
ajlm-2613	29	1	aminu kano teaching hospital	ORG
ajlm-2613	29	2	700	CARDINAL
ajlm-2613	30	1	the histopathology department of	ORG
ajlm-2613	30	2	aminu kano teaching hospital	ORG
ajlm-2613	30	3	5500	CARDINAL
ajlm-2613	31	1	01 january 2015 to	DATE
ajlm-2613	32	1	biodata	PERSON
ajlm-2613	32	2	zero	CARDINAL
ajlm-2613	35	1	the world health organization classification	ORG
ajlm-2613	35	2	two	CARDINAL
ajlm-2613	35	3	houston	GPE
ajlm-2613	35	4	texas	GPE
ajlm-2613	35	5	united states	GPE
ajlm-2613	37	1	1:500	CARDINAL
ajlm-2613	38	1	110	CARDINAL
ajlm-2613	38	2	jinan	GPE
ajlm-2613	38	3	shandong	GPE
ajlm-2613	38	4	china	GPE
ajlm-2613	38	5	lc-4k-2 centrifuge	ORG
ajlm-2613	38	6	jinan	GPE
ajlm-2613	38	7	shandong	GPE
ajlm-2613	38	8	china	GPE
ajlm-2613	40	1	3	CARDINAL
ajlm-2613	40	2	bk-2218	PRODUCT
ajlm-2613	40	3	jinan	GPE
ajlm-2613	40	4	shandong	GPE
ajlm-2613	40	5	china	GPE
ajlm-2613	41	1	2	CARDINAL
ajlm-2613	41	2	60 °	QUANTITY
ajlm-2613	42	1	central drug house ltd	ORG
ajlm-2613	42	2	new delhi	GPE
ajlm-2613	42	3	india	GPE
ajlm-2613	42	4	1 min	DATE
ajlm-2613	42	5	100%	PERCENT
ajlm-2613	42	6	95%	PERCENT
ajlm-2613	42	7	70%	PERCENT
ajlm-2613	42	8	1 min	TIME
ajlm-2613	43	1	100 ml	QUANTITY
ajlm-2613	43	2	central drug house ltd	ORG
ajlm-2613	43	3	new delhi	GPE
ajlm-2613	43	4	india	GPE
ajlm-2613	43	5	8	CARDINAL
ajlm-2613	43	6	chongqing	GPE
ajlm-2613	43	7	jiulongpo	GPE
ajlm-2613	43	8	chongqing	GPE
ajlm-2613	43	9	china	GPE
ajlm-2613	43	10	100 °	QUANTITY
ajlm-2613	43	11	15 min –	TIME
ajlm-2613	43	12	20 min	QUANTITY
ajlm-2613	44	1	central drug house ltd	ORG
ajlm-2613	44	2	new delhi	GPE
ajlm-2613	44	3	india	GPE
ajlm-2613	44	4	3 min	TIME
ajlm-2613	45	1	2 min	TIME
ajlm-2613	45	2	3%	PERCENT
ajlm-2613	45	3	10 min	TIME
ajlm-2613	46	1	2 min	TIME
ajlm-2613	46	2	houston	GPE
ajlm-2613	46	3	texas	GPE
ajlm-2613	46	4	united states	GPE
ajlm-2613	46	5	10 min	DATE
ajlm-2613	46	6	1	CARDINAL
ajlm-2613	46	7	1.5%	PERCENT
ajlm-2613	46	8	central drug house ltd	ORG
ajlm-2613	46	9	new delhi	GPE
ajlm-2613	46	10	india	GPE
ajlm-2613	47	1	30 min with	TIME
ajlm-2613	47	2	200	CARDINAL
ajlm-2613	47	3	houston	GPE
ajlm-2613	47	4	texas	GPE
ajlm-2613	47	5	united states	GPE
ajlm-2613	49	1	streptavidin	GPE
ajlm-2613	49	2	dako	PERSON
ajlm-2613	49	3	copenhagen	GPE
ajlm-2613	49	4	denmark	GPE
ajlm-2613	50	1	3,3	CARDINAL
ajlm-2613	50	2	dako	PERSON
ajlm-2613	50	3	3,3	CARDINAL
ajlm-2613	50	4	3	CARDINAL
ajlm-2613	50	5	3 min	TIME
ajlm-2613	50	6	central drug house ltd	ORG
ajlm-2613	50	7	new delhi	GPE
ajlm-2613	50	8	india	GPE
ajlm-2613	52	1	central drug house ltd	ORG
ajlm-2613	52	2	new delhi	GPE
ajlm-2613	52	3	india	GPE
ajlm-2613	53	1	leica microscope	PERSON
ajlm-2613	53	2	leica microsystems	PERSON
ajlm-2613	53	3	hessen	GPE
ajlm-2613	53	4	germany	GPE
ajlm-2613	53	5	1	CARDINAL
ajlm-2613	53	6	2	CARDINAL
ajlm-2613	53	7	3	CARDINAL
ajlm-2613	54	1	0	CARDINAL
ajlm-2613	54	2	1	CARDINAL
ajlm-2613	54	3	1%	PERCENT
ajlm-2613	54	4	10%	PERCENT
ajlm-2613	54	5	2	CARDINAL
ajlm-2613	54	6	11%	PERCENT
ajlm-2613	54	7	50%	PERCENT
ajlm-2613	54	8	3	CARDINAL
ajlm-2613	54	9	51%	PERCENT
ajlm-2613	54	10	80%	PERCENT
ajlm-2613	54	11	4	CARDINAL
ajlm-2613	54	12	80%	PERCENT
ajlm-2613	55	1	9–12	CARDINAL
ajlm-2613	55	2	1–4	CARDINAL
ajlm-2613	55	3	0	CARDINAL
ajlm-2613	56	1	5 to 12	CARDINAL
ajlm-2613	56	2	1	CARDINAL
ajlm-2613	57	1	1	CARDINAL
ajlm-2613	57	2	aminu kano teaching hospital	ORG
ajlm-2613	57	3	kano	GPE
ajlm-2613	57	4	nigeria	GPE
ajlm-2613	57	5	january 2015	DATE
ajlm-2613	57	6	december 2019	DATE
ajlm-2613	58	1	social sciences	ORG
ajlm-2613	58	2	25	CARDINAL
ajlm-2613	58	3	ibm® corp	ORG
ajlm-2613	58	4	armonk	GPE
ajlm-2613	58	5	new york	GPE
ajlm-2613	58	6	united states	GPE
ajlm-2613	59	1	chi-square	PERSON
ajlm-2613	59	2	0.05	CARDINAL
ajlm-2613	61	1	twenty-nine	QUANTITY
ajlm-2613	61	2	26	CARDINAL
ajlm-2613	62	1	12 years to 80 years	DATE
ajlm-2613	62	2	53.4	CARDINAL
ajlm-2613	62	3	16.0) years	DATE
ajlm-2613	63	1	23	CARDINAL
ajlm-2613	63	2	29	CARDINAL
ajlm-2613	63	3	79.3%	PERCENT
ajlm-2613	63	4	40 years to	DATE
ajlm-2613	63	5	79 years	DATE
ajlm-2613	63	6	the 6th decade	DATE
ajlm-2613	64	1	eleven	CARDINAL
ajlm-2613	64	2	37.9%	PERCENT
ajlm-2613	64	3	age 50 years	DATE
ajlm-2613	64	4	only six	CARDINAL
ajlm-2613	64	5	20.7%	PERCENT
ajlm-2613	64	6	age 70 years	DATE
ajlm-2613	64	7	2	CARDINAL
ajlm-2613	65	1	2	CARDINAL
ajlm-2613	65	2	aminu kano teaching hospital	ORG
ajlm-2613	65	3	kano	GPE
ajlm-2613	65	4	nigeria	GPE
ajlm-2613	65	5	january 2015	DATE
ajlm-2613	65	6	december 2019	DATE
ajlm-2613	66	1	20	CARDINAL
ajlm-2613	66	2	2.2:1	CARDINAL
ajlm-2613	67	1	12 years to 75 years	DATE
ajlm-2613	68	1	nine	CARDINAL
ajlm-2613	68	2	39 years to 80 years	DATE
ajlm-2613	68	3	2	CARDINAL
ajlm-2613	69	1	eighteen	DATE
ajlm-2613	69	2	62.1%	PERCENT
ajlm-2613	69	3	eight	CARDINAL
ajlm-2613	70	1	eight	CARDINAL
ajlm-2613	70	2	27.6%	PERCENT
ajlm-2613	70	3	five	CARDINAL
ajlm-2613	70	4	only three	CARDINAL
ajlm-2613	70	5	10.3%	PERCENT
ajlm-2613	70	6	one	CARDINAL
ajlm-2613	70	7	1	CARDINAL
ajlm-2613	71	1	15.8538 degrees	QUANTITY
ajlm-2613	71	2	14	CARDINAL
ajlm-2613	71	3	2	CARDINAL
ajlm-2613	71	4	0.8812	CARDINAL
ajlm-2613	72	1	1	CARDINAL
ajlm-2613	72	2	haematoxylin	PERSON
ajlm-2613	72	3	aminu kano teaching hospital	ORG
ajlm-2613	72	4	kano	GPE
ajlm-2613	72	5	nigeria	GPE
ajlm-2613	74	1	fifteen	CARDINAL
ajlm-2613	74	2	51.7%	PERCENT
ajlm-2613	74	3	2	CARDINAL
ajlm-2613	75	1	nine	CARDINAL
ajlm-2613	75	2	five	CARDINAL
ajlm-2613	75	3	one	CARDINAL
ajlm-2613	76	1	fourteen	CARDINAL
ajlm-2613	76	2	48.3%	PERCENT
ajlm-2613	77	1	only five	CARDINAL
ajlm-2613	77	2	33.3%	PERCENT
ajlm-2613	77	3	four	CARDINAL
ajlm-2613	77	4	28.6%	PERCENT
ajlm-2613	78	1	8.8808	CARDINAL
ajlm-2613	78	2	7	CARDINAL
ajlm-2613	78	3	0.2613	CARDINAL
ajlm-2613	78	4	0.0762	CARDINAL
ajlm-2613	78	5	1	CARDINAL
ajlm-2613	79	1	thirteen	CARDINAL
ajlm-2613	79	2	44.8%	PERCENT
ajlm-2613	79	3	2	CARDINAL
ajlm-2613	80	1	5.2217	CARDINAL
ajlm-2613	80	2	7	CARDINAL
ajlm-2613	81	1	cox-2 positivity	ORG
ajlm-2613	81	2	60-year-old	DATE
ajlm-2613	81	3	1	CARDINAL
ajlm-2613	83	1	2.2:1	CARDINAL
ajlm-2613	83	2	40–79 years	DATE
ajlm-2613	83	3	62.1%	PERCENT
ajlm-2613	83	4	27.6%	PERCENT
ajlm-2613	83	5	10.3%	PERCENT
ajlm-2613	84	1	3.4%	PERCENT
ajlm-2613	87	1	53.4	CARDINAL
ajlm-2613	87	2	16.00	CARDINAL
ajlm-2613	87	3	the 5th decade	DATE
ajlm-2613	88	1	ibrahim	PERSON
ajlm-2613	88	2	dahiru	PERSON
ajlm-2613	88	3	china	GPE
ajlm-2613	88	4	65 years.22	QUANTITY
ajlm-2613	88	5	africa	LOC
ajlm-2613	88	6	asia	LOC
ajlm-2613	88	7	the united states	GPE
ajlm-2613	88	8	the united kingdom	GPE
ajlm-2613	88	9	64 years	DATE
ajlm-2613	88	10	68 years	DATE
ajlm-2613	89	1	62.1%	PERCENT
ajlm-2613	89	2	51.7%	PERCENT
ajlm-2613	90	1	3.4%	PERCENT
ajlm-2613	90	2	1	CARDINAL
ajlm-2613	90	3	29	CARDINAL
ajlm-2613	92	1	38% to 100%	PERCENT
ajlm-2613	92	2	mutation.35,36	PRODUCT
ajlm-2613	92	3	several years	DATE
ajlm-2613	94	1	cox-2	GPE
ajlm-2613	95	1	37.9%	PERCENT
ajlm-2613	95	2	39	CARDINAL
ajlm-2613	95	3	90.9%	PERCENT
ajlm-2613	95	4	63.3%	PERCENT
ajlm-2613	95	5	36.4%).36	CARDINAL
ajlm-2613	95	6	nine	CARDINAL
ajlm-2613	95	7	crc	ORG
ajlm-2613	95	8	12	CARDINAL
ajlm-2613	95	9	japan	GPE
ajlm-2613	95	10	bamba et al	PERSON
ajlm-2613	95	11	study.37	PRODUCT
ajlm-2613	95	12	3.4%	PERCENT
ajlm-2613	95	13	1	CARDINAL
ajlm-2613	95	14	29	CARDINAL
ajlm-2613	95	15	cox-2	ORG
ajlm-2613	96	1	non-african	NORP
ajlm-2613	96	2	three	CARDINAL
ajlm-2613	97	1	africa	LOC
ajlm-2613	97	2	america	GPE
ajlm-2613	97	3	asian	NORP
ajlm-2613	98	1	apc	ORG
ajlm-2613	100	1	nigeria	GPE
ajlm-2613	100	2	africa	LOC
ajlm-2613	102	1	africa	LOC
ajlm-2613	102	2	africa	LOC
ajlm-2613	104	1	62.1%	PERCENT
ajlm-2613	104	2	51.7%	PERCENT
ajlm-2613	105	1	3.4%	PERCENT
ajlm-2613	107	1	first	ORDINAL
ajlm-2613	108	1	a.a.j.	GPE
ajlm-2613	108	2	z.a.a.	GPE
ajlm-2613	109	1	a.a.j.	ORG
ajlm-2613	109	2	z.a.a.	GPE
ajlm-2613	111	1	a.a.j.	ORG
ajlm-2613	111	2	z.a.a.	GPE
ajlm-2613	117	1	ray-offor e	PERSON
ajlm-2613	118	1	harcourt	GPE
ajlm-2613	118	2	nigeria	GPE
ajlm-2613	119	1	gastroenterol insights	PERSON
ajlm-2613	120	1	2019;10(1):7987	CARDINAL
ajlm-2613	121	1	lagos	GPE
ajlm-2613	121	2	nigeria	GPE
ajlm-2613	122	1	pan afr med	PERSON
ajlm-2613	122	2	j. 2016;24:333	PERSON
ajlm-2613	123	1	ibrahim y	PERSON
ajlm-2613	123	2	dahiru amc	PERSON
ajlm-2613	123	3	ten year	DATE
ajlm-2613	124	1	bom j. 2018;15(1):35–42	PERSON
ajlm-2613	124	2	bojuwoye	ORG
ajlm-2613	124	3	mo	GPE
ajlm-2613	124	4	olokoba ab	PERSON
ajlm-2613	124	5	ogunmodede ja	PERSON
ajlm-2613	125	1	north central nigeria	LOC
ajlm-2613	126	1	sud j med sci	ORG
ajlm-2613	127	1	2018;13(4):277–288	CARDINAL
ajlm-2613	128	1	arigbabu ao	PERSON
ajlm-2613	128	2	agbakwuru ae	PERSON
ajlm-2613	128	3	nigerians	NORP
ajlm-2613	129	1	niger j clin pract	ORG
ajlm-2613	130	1	2014;17(6):756–762	CARDINAL
ajlm-2613	131	1	clin gastroenterol	PERSON
ajlm-2613	132	1	2010;24(3):271–280	CARDINAL
ajlm-2613	133	1	lasser ke	PERSON
ajlm-2613	133	2	roy hk	PERSON
ajlm-2613	135	1	j gastrointest oncol	PERSON
ajlm-2613	136	1	2016;8(12):826–834	CARDINAL
ajlm-2613	137	1	paydar m	ORG
ajlm-2613	137	2	namin hh	PERSON
ajlm-2613	138	1	african americans	NORP
ajlm-2613	138	2	hispanic	NORP
ajlm-2613	138	3	americans	NORP
ajlm-2613	139	1	dis sci	PERSON
ajlm-2613	140	1	2013;59(2):446–450	CARDINAL
ajlm-2613	141	1	https://doi.org/10.1007/s10620-013-2898-0	NORP
ajlm-2613	141	2	zheng xe	PERSON
ajlm-2613	141	3	hurtado-cordovi j	GPE
ajlm-2613	141	4	new york	GPE
ajlm-2613	142	1	j gastrointest	PERSON
ajlm-2613	143	1	2013;44(3):270–276	CARDINAL
ajlm-2613	144	1	yousef	PERSON
ajlm-2613	144	2	jordanian	NORP
ajlm-2613	145	1	turk	NORP
ajlm-2613	145	2	j gastroenterol	PERSON
ajlm-2613	146	1	2015;26(2):154–158	CARDINAL
ajlm-2613	147	1	loomans-kropp	PERSON
ajlm-2613	147	2	pinsky p	PERSON
ajlm-2613	147	3	chan	PERSON
ajlm-2613	147	4	umar a. association	PERSON
ajlm-2613	149	1	2019;2(12):e1916729	CARDINAL
ajlm-2613	150	1	liao x	PERSON
ajlm-2613	153	1	2012;367:1596–1606	CARDINAL
ajlm-2613	154	1	https://doi.org/10.1056/nejmoa1207756 fink sp, yamauchi m	ORG
ajlm-2613	154	2	15	CARDINAL
ajlm-2613	154	3	sci transl	ORG
ajlm-2613	156	1	nan h	GPE
ajlm-2613	156	2	morikawa t	PERSON
ajlm-2613	156	3	8q24	CARDINAL
ajlm-2613	156	4	ctnnb1	ORG
ajlm-2613	159	1	claria j. cyclooxygenase-2 biology	PERSON
ajlm-2613	160	1	curr pharm des	ORG
ajlm-2613	160	2	2003;9(27):2177–2190	CARDINAL
ajlm-2613	162	1	fu l	GPE
ajlm-2613	162	2	guo l	GPE
ajlm-2613	162	3	dubois rn	GPE
ajlm-2613	166	1	https://doi.org/10.1053/j.gastro.2015.07.064 xu l	PERSON
ajlm-2613	166	2	stevens j	PERSON
ajlm-2613	166	3	hilton mb	PERSON
ajlm-2613	168	1	sci transl med	ORG
ajlm-2613	169	1	2014;6(242):242ra84	CARDINAL
ajlm-2613	169	2	https://doi.org/10.1126/scitranslmed.3008455 wu	PERSON
ajlm-2613	169	3	sun g-p.	PERSON
ajlm-2613	170	1	j gastroenterol	PERSON
ajlm-2613	171	1	2015;21(20):6206–6214	CARDINAL
ajlm-2613	172	1	arends mj	PERSON
ajlm-2613	172	2	lam ak	ORG
ajlm-2613	174	1	5th	ORDINAL
ajlm-2613	175	1	lyon	PERSON
ajlm-2613	175	2	2019	DATE
ajlm-2613	176	1	156–213	CARDINAL
ajlm-2613	177	1	dannenberg aj	PERSON
ajlm-2613	177	2	cox-2	GPE
ajlm-2613	179	1	2000;89:2637–2645	CARDINAL
ajlm-2613	184	1	hong w	GPE
ajlm-2613	184	2	dong l	ORG
ajlm-2613	184	3	zippi m	PERSON
ajlm-2613	184	4	zhou m.	PERSON
ajlm-2613	184	5	china	GPE
ajlm-2613	186	1	2018;10	CARDINAL
ajlm-2613	187	1	2743–2755	CARDINAL
ajlm-2613	188	1	nouraie m	ORG
ajlm-2613	188	2	smoot	PERSON
ajlm-2613	188	3	african-americans	NORP
ajlm-2613	189	1	dis sci.	PERSON
ajlm-2613	190	1	lim	PERSON
ajlm-2613	190	2	mahesh	PERSON
ajlm-2613	190	3	singh	GPE
ajlm-2613	190	4	uk	GPE
ajlm-2613	191	1	j gastroenterol	PERSON
ajlm-2613	193	1	https://doi.org/10.3748/wjg.v16.i42.5324 ashktorab h	ORG
ajlm-2613	193	2	paydar m	ORG
ajlm-2613	193	3	yazdi s	PERSON
ajlm-2613	193	4	african americans	NORP
ajlm-2613	194	1	2014;22(5):1387–1391	CARDINAL
ajlm-2613	196	1	physiol rev	PERSON
ajlm-2613	196	2	2013;93(1):359–404	DATE
ajlm-2613	197	1	bassett jk	PERSON
ajlm-2613	197	2	severi g	PERSON
ajlm-2613	197	3	english	NORP
ajlm-2613	198	1	epidemiol biomark	PERSON
ajlm-2613	199	1	2010;19(11):2978–2986	CARDINAL
ajlm-2613	200	1	https://doi.org/10.1158/1055-9965.epi-10-0543 chang lc	PERSON
ajlm-2613	200	2	wu ms	PERSON
ajlm-2613	200	3	tu ch	PERSON
ajlm-2613	200	4	lee yc	PERSON
ajlm-2613	200	5	chiu	PERSON
ajlm-2613	201	1	gastrointest endosc	PERSON
ajlm-2613	202	1	https://doi.org/10.1016/j.gie.2013.11.035 bates b	PERSON
ajlm-2613	202	2	cox l	ORG
ajlm-2613	202	3	nicholson s	PERSON
ajlm-2613	202	4	years 5 and 6	DATE
ajlm-2613	202	5	2012/2013–2013/2014	CARDINAL
ajlm-2613	203	1	london	GPE
ajlm-2613	203	2	2016	DATE
ajlm-2613	204	1	kitamura t	ORG
ajlm-2613	204	2	noda	GPE
ajlm-2613	205	1	sci	ORG
ajlm-2613	205	2	2003;94(7):618–621	CARDINAL
ajlm-2613	206	1	kelly b	PERSON
ajlm-2613	206	2	semenza gl	PERSON
ajlm-2613	206	3	1	CARDINAL
ajlm-2613	208	1	2003;63:2330–2334	CARDINAL
ajlm-2613	209	1	sato t	ORG
ajlm-2613	210	1	jpn j clin oncol	PERSON
ajlm-2613	211	1	2003;33(12)631–635	CARDINAL
ajlm-2613	211	2	baker ja	PERSON
ajlm-2613	214	1	https://doi.org/10.1002/path.1232 watanabe k	PERSON
ajlm-2613	215	1	ono-8713	DATE
ajlm-2613	217	1	2000;156(1):57–61	DATE
ajlm-2613	217	2	https://doi.org/10.1016/s0304-3835(00)00440-7 kotani m	PERSON
ajlm-2613	217	3	tanaka	PERSON
ajlm-2613	217	4	ogawa y	PERSON
ajlm-2613	220	1	1997;40(3):425–434	DATE
ajlm-2613	221	1	aoki t	PERSON
ajlm-2613	221	2	narumiya s. prostaglandin e2-ep2	ORG
ajlm-2613	224	1	2017;37:4	PERSON
ajlm-2613	224	2	https://doi.org/10.1186/s41232-017-0036-7 bamba h	ORG
ajlm-2613	224	3	ota	ORG
ajlm-2613	224	4	adachi	GPE
ajlm-2613	224	5	itoyama	PERSON
ajlm-2613	224	6	matsuzaki f. high expression	PERSON
ajlm-2613	226	1	1999;83(4):470–475	CARDINAL
ajlm-2613	227	1	apc	ORG
ajlm-2613	229	1	2001;21(2a):911–915	CARDINAL
ajlm-2613	229	2	fujita m	ORG
ajlm-2613	229	3	fukui h	GPE
ajlm-2613	229	4	k-ras	ORG
ajlm-2613	230	1	j gastroenterol	PERSON